Gregory Renza
Stock Analyst at Truist Securities
(3.33)
# 971
Out of 5,170 analysts
255
Total ratings
38.79%
Success rate
5.11%
Average return
Main Sectors:
Stocks Rated by Gregory Renza
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ONC BeOne Medicines AG | Maintains: Buy | $400 → $412 | $282.72 | +45.73% | 4 | Feb 27, 2026 | |
| GILD Gilead Sciences | Maintains: Buy | $145 → $152 | $141.11 | +7.72% | 3 | Feb 11, 2026 | |
| CGON CG Oncology | Maintains: Buy | $66 → $75 | $65.86 | +13.88% | 6 | Feb 10, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $820 → $818 | $737.45 | +10.92% | 3 | Feb 2, 2026 | |
| VRDN Viridian Therapeutics | Maintains: Buy | $41 → $40 | $27.84 | +43.68% | 13 | Jan 8, 2026 | |
| AMGN Amgen | Maintains: Hold | $318 → $319 | $349.92 | -8.84% | 19 | Jan 8, 2026 | |
| IDYA IDEAYA Biosciences | Maintains: Buy | $59 → $60 | $32.60 | +84.05% | 14 | Jan 6, 2026 | |
| AGIO Agios Pharmaceuticals | Maintains: Buy | $32 → $38 | $27.92 | +36.10% | 8 | Dec 24, 2025 | |
| FULC Fulcrum Therapeutics | Maintains: Buy | $14 → $18 | $7.04 | +155.68% | 5 | Dec 11, 2025 | |
| CATX Perspective Therapeutics | Assumes: Buy | $8 → $12 | $4.60 | +160.87% | 7 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $23 → $30 | $14.92 | +101.07% | 12 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $29 | $12.12 | +139.27% | 10 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $4.26 | +158.22% | 7 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $140 | $97.06 | +44.24% | 1 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $2.52 | +257.14% | 2 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $10 | $4.55 | +119.78% | 4 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $51 | $22.04 | +131.40% | 1 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $140 | $123.03 | +13.80% | 1 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $45 → $50 | $41.26 | +21.18% | 11 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $26 | $20.72 | +25.48% | 16 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $8 | $4.04 | +98.02% | 12 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $5 | $1.65 | +203.03% | 11 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $182 → $172 | $181.80 | -5.39% | 14 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $113 → $38 | $59.05 | -36.49% | 14 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $12 | $6.30 | +90.48% | 6 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $16 → $14 | $5.82 | +140.55% | 10 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $18 | $22.57 | -20.25% | 11 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $68 → $48 | $1.22 | +3,834.43% | 4 | Jan 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $110 → $20 | $5.80 | +244.83% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $16 | $0.83 | +1,833.30% | 7 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $2,160 → $180 | $14.22 | +1,165.82% | 4 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $100 → $80 | $0.77 | +10,289.61% | 5 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $105 → $30 | $0.17 | +17,484.99% | 3 | Jun 2, 2020 |
BeOne Medicines AG
Feb 27, 2026
Maintains: Buy
Price Target: $400 → $412
Current: $282.72
Upside: +45.73%
Gilead Sciences
Feb 11, 2026
Maintains: Buy
Price Target: $145 → $152
Current: $141.11
Upside: +7.72%
CG Oncology
Feb 10, 2026
Maintains: Buy
Price Target: $66 → $75
Current: $65.86
Upside: +13.88%
Regeneron Pharmaceuticals
Feb 2, 2026
Maintains: Buy
Price Target: $820 → $818
Current: $737.45
Upside: +10.92%
Viridian Therapeutics
Jan 8, 2026
Maintains: Buy
Price Target: $41 → $40
Current: $27.84
Upside: +43.68%
Amgen
Jan 8, 2026
Maintains: Hold
Price Target: $318 → $319
Current: $349.92
Upside: -8.84%
IDEAYA Biosciences
Jan 6, 2026
Maintains: Buy
Price Target: $59 → $60
Current: $32.60
Upside: +84.05%
Agios Pharmaceuticals
Dec 24, 2025
Maintains: Buy
Price Target: $32 → $38
Current: $27.92
Upside: +36.10%
Fulcrum Therapeutics
Dec 11, 2025
Maintains: Buy
Price Target: $14 → $18
Current: $7.04
Upside: +155.68%
Perspective Therapeutics
Nov 24, 2025
Assumes: Buy
Price Target: $8 → $12
Current: $4.60
Upside: +160.87%
Nov 24, 2025
Assumes: Buy
Price Target: $23 → $30
Current: $14.92
Upside: +101.07%
Nov 24, 2025
Initiates: Buy
Price Target: $29
Current: $12.12
Upside: +139.27%
Nov 24, 2025
Initiates: Buy
Price Target: $11
Current: $4.26
Upside: +158.22%
Nov 24, 2025
Initiates: Buy
Price Target: $140
Current: $97.06
Upside: +44.24%
Nov 24, 2025
Initiates: Buy
Price Target: $9
Current: $2.52
Upside: +257.14%
Nov 24, 2025
Initiates: Hold
Price Target: $10
Current: $4.55
Upside: +119.78%
Nov 24, 2025
Initiates: Buy
Price Target: $51
Current: $22.04
Upside: +131.40%
Nov 24, 2025
Initiates: Buy
Price Target: $140
Current: $123.03
Upside: +13.80%
Jul 8, 2025
Downgrades: Sector Perform
Price Target: $45 → $50
Current: $41.26
Upside: +21.18%
May 19, 2025
Reiterates: Outperform
Price Target: $26
Current: $20.72
Upside: +25.48%
May 15, 2025
Reiterates: Outperform
Price Target: $8
Current: $4.04
Upside: +98.02%
May 14, 2025
Reiterates: Sector Perform
Price Target: $5
Current: $1.65
Upside: +203.03%
May 7, 2025
Maintains: Outperform
Price Target: $182 → $172
Current: $181.80
Upside: -5.39%
Apr 16, 2025
Maintains: Sector Perform
Price Target: $113 → $38
Current: $59.05
Upside: -36.49%
Mar 26, 2025
Reiterates: Outperform
Price Target: $12
Current: $6.30
Upside: +90.48%
Mar 21, 2025
Maintains: Outperform
Price Target: $16 → $14
Current: $5.82
Upside: +140.55%
Jan 14, 2025
Reiterates: Sector Perform
Price Target: $18
Current: $22.57
Upside: -20.25%
Jan 9, 2025
Maintains: Outperform
Price Target: $68 → $48
Current: $1.22
Upside: +3,834.43%
Nov 5, 2024
Downgrades: Sector Perform
Price Target: $110 → $20
Current: $5.80
Upside: +244.83%
Aug 14, 2024
Reiterates: Outperform
Price Target: $16
Current: $0.83
Upside: +1,833.30%
Jun 27, 2023
Downgrades: Sector Perform
Price Target: $2,160 → $180
Current: $14.22
Upside: +1,165.82%
Mar 16, 2022
Maintains: Sector Perform
Price Target: $100 → $80
Current: $0.77
Upside: +10,289.61%
Jun 2, 2020
Downgrades: Sector Perform
Price Target: $105 → $30
Current: $0.17
Upside: +17,484.99%